Recombinant Mouse Ceramide synthase 4 (Cers4)

What is the functional role of CERS4 in sphingolipid metabolism?

CERS4 catalyzes an amide bond formation between a sphingoid base and a fatty acyl-coenzyme A during ceramide synthesis . It specifically participates in the N-acylation of sphinganine to dihydroceramide, which is subsequently reduced to ceramide by dihydroceramide desaturase . This reaction represents a critical step in de novo ceramide synthesis, which begins in the endoplasmic reticulum with the condensation of L-serine and palmitoyl-CoA by serine palmitoyl transferase . CERS4, like other ceramide synthases, has specificity for certain fatty acyl chain lengths, contributing to the diversity of ceramide species in cellular membranes .

How is CERS4 expression measured in research settings?

CERS4 expression is typically measured using multiple complementary techniques:

• Transcriptional level analysis: Reverse transcription polymerase chain reaction (RT-PCR) and quantitative PCR (qPCR) are employed to assess mRNA levels .

• Protein level analysis: Western blot analysis using specific anti-CERS4 antibodies (e.g., ab118379 from Abcam at 1:2,000 dilution) is commonly used .

• Clinical sample analysis: For determining optimal expression cut-off values in disease studies, ROC analyses may be performed. In colorectal cancer research, a CERS4 cut-off value of 0.800 produced optimal results with an AUC of 0.694 (sensitivity: 0.83, specificity: 0.35) .

Where is CERS4 localized in mammalian cells?

CERS4 is primarily localized in the endoplasmic reticulum (ER) membrane . This localization is consistent with its role in de novo ceramide synthesis, where sphinganine is acylated to form dihydroceramide. After ceramide synthesis in the ER, the product is transported to the Golgi apparatus via vesicular trafficking or by the ceramide transfer protein (CERT) for further metabolism into complex sphingolipids . In specific tissues, CERS4 shows distinct expression patterns - it is highly expressed in the epidermis of adult mice and is localized in defined populations within the interfollicular epidermis and hair follicle sebaceous unit .

How can CERS4 activity be measured in vitro?

Measuring CERS4 activity in vitro involves several methodological approaches:

• Enzymatic assays: Incubating purified recombinant enzyme or cell lysates with sphinganine and specific acyl-CoA substrates, followed by lipid extraction and analysis of dihydroceramide production.

• Analytical techniques: Products can be measured using thin-layer chromatography (TLC), high-performance liquid chromatography (HPLC), or liquid chromatography-mass spectrometry (LC-MS).

• Cell-based assays: For evaluating CERS4 function in cellular contexts, metabolic labeling with radiolabeled precursors can track ceramide synthesis.

• Colony formation assays: As demonstrated in HepG2 liver cancer cells, where cells are plated (500 cells/well), cultured for ~2 weeks, stained with crystal violet solution (1% crystal violet and 10% ethanol), and colonies counted to assess proliferation capacity following CERS4 modulation .

What is the relationship between CERS4 expression and KRAS mutations in cancer models?

Research has revealed a significant inverse relationship between CERS4 expression and KRAS mutations in colorectal cancer (CRC). Key findings include:

• CERS4 expression is significantly lower in KRAS-mutant CRC compared to wild-type KRAS CRC tissues (p = 0.004) .

• ROC analyses established an optimal cut-off value of 0.800 for CERS4 expression, with an AUC of 0.694 (sensitivity: 0.83, specificity: 0.35) .

• This relationship suggests CERS4 may function as a potential biomarker for KRAS mutation status in CRC .

Two potential mechanisms have been proposed to explain this relationship:

• The Wnt pathway may be involved in both CERS4 regulation and KRAS mutation in CRC.

• Direct signaling interactions might exist between KRAS and ceramide metabolism pathways .

Understanding this relationship could be crucial for developing targeted therapies for KRAS-mutant cancers, which are often resistant to standard treatments like cetuximab .

How does CERS4 regulate tumor growth and proliferation?

CERS4 plays significant roles in regulating tumor growth and proliferation through several mechanisms:

• In liver cancer: High CERS4 expression correlates with increased cell proliferation. When CERS4 is silenced in HepG2 and Huh7 liver cancer cells, proliferation rates are significantly suppressed (p<0.001) .

• In vivo effects: Silencing CERS4 in liver cancer cells leads to reduced tumor weight and volume in Balb/c nude mice models .

• Molecular pathway involvement: The NF-κB signaling pathway is affected following CERS4 knockdown, suggesting this pathway mediates some of CERS4's proliferative effects .

• Sphingolipid balance: CERS4 may modulate the balance between pro-apoptotic ceramides and pro-survival sphingolipid metabolites.

These findings indicate that CERS4 is an important regulator of liver cancer cell proliferation and could serve as a potential anticancer therapeutic target and diagnostic biomarker .

What is the relationship between CERS4 and vascular invasion in cancer?

CERS4 expression correlates with vascular invasion in colorectal cancer:

• Clinical studies show that high CERS4 expression is associated with increased vascular invasion in colorectal cancer patients (p = 0.0057) .

• The mechanism appears to involve sphingolipid-mediated effects on vascular integrity.

• Ceramides produced by CERS4 are precursors to sphingosine-1-phosphate (S1P), a blood-borne lipid mediator that regulates vascular systems .

• Blood flow and circulating S1P activate endothelial S1P1 receptors to stabilize blood vessels in development and homeostasis .

• When CERS4 expression is reduced (as in KRAS-mutant cancers), ceramide levels decrease, potentially affecting downstream S1P production and vascular stability.

• Paradoxically, among CRCs with decreased CERS4, there were significantly more cases with venous invasion than in cases where CERS4 was not decreased .

This complex relationship suggests CERS4's dual role in tumor progression and vascular invasion, making it an important target for understanding cancer metastasis.

How does CERS4 relate to the Wnt/β-catenin signaling pathway?

The connection between CERS4 and the Wnt/β-catenin signaling pathway has been observed in experimental models:

• Studies in mice showed that decreased bone morphogenetic protein (BMP) signaling in CERS4−/− mice may promote Wnt/β-catenin signaling .

• This enhanced Wnt activity strongly stimulates the activation of hair follicle stem cells .

• In colorectal cancer contexts, where Wnt pathway dysregulation is a key driver of carcinogenesis, reduced CERS4 expression in KRAS-mutant tumors suggests a potential regulatory relationship with Wnt signaling .

• While direct mechanistic evidence linking CERS4 suppression to Wnt pathway activation in colorectal cancer is still being investigated, it represents a plausible hypothesis for how CERS4 influences cancer development .

What experimental approaches are used to study CERS4 function in cancer models?

Several experimental approaches have been employed to study CERS4 function in cancer:

Cell Culture Studies:

• Human cancer cell lines (HepG2 and Huh7 for liver cancer, various CRC lines)

• Lentivirus-mediated RNA interference to silence CERS4 expression

• MTT assays to measure cell proliferation at multiple time points (12, 24, 48, 72, and 96 hours)

• Colony formation assays using crystal violet staining

Protein Analysis:

• Western blotting with specific antibodies (anti-CERS4 at 1:2,000 dilution)

• Analysis of related signaling pathways (e.g., NF-κB)

In Vivo Models:

• Balb/c nude mice with xenografts of CERS4-silenced cancer cells

• Measurement of tumor weight and volume

Clinical Samples:

• Analysis of CERS4 expression in patient tumor samples

• Correlation with clinical features including KRAS mutation status and vascular invasion

These diverse approaches provide complementary insights into CERS4's multifaceted roles in cancer biology.

What are the effects of CERS4 inhibition in different experimental models?

CERS4 inhibition produces diverse effects across different experimental models:

These results highlight CERS4 as an important regulator of cancer cell proliferation and tumor growth, suggesting its potential as a therapeutic target.

How do ceramide synthases like CERS4 contribute to cancer and tumor suppression?

Ceramide synthases, including CERS4, play complex roles in cancer development and suppression:

• Different CerS display remarkable differences in their biological properties, with each playing distinct roles in cancer and tumor suppression .

• CERS4 appears to have context-dependent effects, functioning as a potential oncogenic factor in liver cancer, where its high expression correlates with increased proliferation .

• In colorectal cancer with KRAS mutations, reduced CERS4 expression correlates with disease characteristics, suggesting tumor-suppressive functions in certain contexts .

• The diverse effects stem from ceramide's role as an important intracellular signaling molecule involved in regulating differentiation, proliferation, and apoptosis .

• Ceramide synthases influence the response to chemotherapeutic drugs and apoptotic processes, with specific ceramide chain lengths produced by different CerS having distinct biological effects .

This dual nature of CERS4 in different cancer types highlights the complexity of sphingolipid metabolism in tumorigenesis and the need for context-specific therapeutic approaches.

What methodological considerations are important when working with recombinant mouse CERS4?

When working with recombinant mouse CERS4, several methodological considerations are critical:

• Expression systems: As a multi-pass membrane protein, CERS4 requires appropriate expression systems that support proper membrane integration and folding.

• Enzymatic activity assays: When assessing activity, researchers should:

  • Ensure proper membrane reconstitution, as CERS4 requires a lipid bilayer environment for optimal activity

  • Consider using radiolabeled substrates ([³H]-sphinganine or [¹⁴C]-acyl-CoA) for enhanced sensitivity

  • Employ appropriate analytical techniques (LC-MS, TLC) to identify specific ceramide species produced

• Genetic manipulation approaches:

  • Lentivirus-mediated RNA interference has been successfully used to silence CERS4 expression in cancer cell lines

  • For functional studies, knockdown should be validated at both mRNA (RT-PCR) and protein levels (Western blot)

• Cell-based experimental design:

  • When assessing proliferation effects, measurements should be taken at multiple time points (e.g., 12, 24, 48, 72, and 96 hours as demonstrated in liver cancer studies)

  • Colony formation assays require proper cell seeding density (e.g., 500 cells/well) and sufficient incubation time (~2 weeks)

• In vivo approaches:

  • Consider using immunodeficient mouse models (e.g., Balb/c nude mice) for xenograft studies of CERS4-manipulated cells